INSTRUMENT FOR MEASURING CARBON MONOXIDE POISONING OF HUMANS USING IN VIVO NIRS TECHNOLOGY

• US 20140073891A1
• Filed: 11/14/2013
• Published: 03/13/2014
• Est. Priority Date: 04/25/2007
• Status: Abandoned Application

• Current Assignee: Neurophysics Corporation
• Original Assignee: Neurophysics Corporation
• Inventors: STODDART, Hugh Franklin, STODDART, Hugh Adam
• Application Number:
  US14/080,079
• Publication Number:
  US 20140073891A1
• Time in Patent Office: Days
• US Class Current: 600/328
• CPC Class Codes: A61B 5/14551 for measuring blood gases
• CPC Class Codes: A61B 5/4845 Toxicology, e.g. by detection of alcohol, drug or toxic products A61B5/4848 takes precedence

Abstract

Spectral absorption based non-invasive procedure for determination of blood constituents utilizing in vivo NIRS (Near-Infrared Spectrum) technology, which is the measurement of the near-infrared absorption spectrum within a region of the living human body for the purpose of identifying tissue and blood components and their concentrations and more particularly to novel applications and methodology for determining the optical response, measurements and calculations relating to the concentrations of individual chromophores in the bloodstream and particularly to the level of CO chromophores in the tissues of an animal or human being.

Claims

1. A method for non-invasively determining the relative amounts of a plurality of chromophores in the blood of a human or animal subject, the method comprising the steps of:

imparting non-continuously a wavelength range of light comprising visible and near-infrared components extending down to at least about 450 nm to a light delivery fiberoptic;

passing the wavelength range of light through a selected tissue sample of the nasal septum of the human or animal subject and receiving a spectral absorption portion of the wavelength range of light in a light collecting fiberoptic;

providing a spectrometer for receiving the spectral absorption portion of the wavelength range of light from the light collecting fiberoptic;

acquiring a first spectrum of the spectral absorption portion of the wavelength range of light;

acquiring a second spectrum of ambient light at a first predetermined time interval from the acquisition of the first spectrum;

acquiring a third reference spectrum of light from the wavelength range of light at a second predetermined time interval from the acquisition of the second spectrum; and

acquiring a fourth spectrum of ambient light at a third predetermined time interval from the acquisition of the reference spectrum;

subtracting an average of the second and fourth ambient light spectrum from each of the first and third spectrum to determine a total absorption spectra of the selected tissue sample for a plurality of wavelengths selected from the wavelength range of light; and

recording light intensity at each and substantially every wavelength in the spectral range of the spectrometer for each of the plurality of wavelengths;

performing decomposition of the total absorption spectra by comparing light intensity at a first wavelength to light intensity at adjacent wavelengths to determine the concentration of the plurality of chromophores;

assembling a catalog of chromophore spectra from the recorded light intensity at each wavelength in the spectral range of the spectrometer for each of the plurality of chromophores separately by measuring each wavelength individually at the determined concentration and recorded wavelength to evaluate the spectral shape to determine the spectral signature for the chromophore;

deconvolving the total absorption spectra to determine a relative contribution of each of the plurality of chromophores in the blood of a human or animal subject; and

identifying at least one chromophore and its concentration in the blood of the human or animal subject from the catalog of chromophore spectra.

2. The method for non-invasively determining the relative amount of at least one chromophore in the blood of a human or animal subject as set forth in claim 1 further comprising the step of impinging the selected tissue surface portion with broadband infrared light.

3. The method for non-invasively determining the relative amount of at least one chromophore in the blood of a human or animal subject as set forth in claim 1 further comprising the step of determining a first absorption value of the light in the hemoglobin of the arterial blood flow through the selected tissue sample and comparing to at least a second absorption value determined at a different time from the first absorption value, and evaluating the rate of change between the first absorption value and the second absorption value.

4. The method for non-invasively determining the relative amount of at least one chromophore in the blood of a human or animal subject as set forth in claim 1 further comprising the step of determining the relative percentages of oxyhemoglobin, carboxyhemoglobin and deoxyhemoglobin in the blood in accordance with multiple wavelength absorption values.

5. The method for non-invasively determining the relative amounts of at least one chromophore in the blood of a human or animal subject as set forth in claim 1 further comprising the steps of performing the deconvolution of the total absorption spectra from the spectrometer using a technique of developing a matrix-vector notation;

(A+γ

I)c=b 

 

(17)

where A is the N×

N matrix with elements a_m,n given by

a_m,n=∫

σ

_m(λ

)σ

_n(λ

)dλ

 

 

(14);

I is the N×

N identity matrix, c is the N-component vector whose elements are the unknown concentrations and b is the N-component vector with elements b_m given by

b_m=∫

σ

_m(λ

)F(λ

)dλ

 

 

(15);

the concentration c which solves

(A+γ

I)c=b 

 

(17)

is formally given by

c=(A+γ

I)<sup>−

1</sup>b 

 

(18)

the result of which determines the quantities or concentrations of chromophores in the blood of a human or animal subject.

6. An apparatus for non-invasively determining the relative amounts of a plurality of chromophores in the blood of a human or animal subject comprising:

a light source imparting a wavelength range including visible and broadband infrared light to a light delivery fiberoptic;

a light emission timing disk having an opening positioned between the light source and the light delivery fiber optic;

a light collecting fiberoptic for receiving the wavelength range of light having passed through a selected tissue sample of the human or animal subject at a predetermined time interval according to the light emission timing disk; and

a spectrometer for measuring the intensity of substantially all wavelengths of light received by the light collecting fiberoptic; and

wherein a decomposition of a total absorption spectra of the measured intensity of substantially all wavelengths of light is performed through a comparison of intensity at a first wavelength to an intensity at one or more adjacent wavelengths to determine the concentration of a plurality of chromophore spectra and a catalog of this chromophore spectra is assembled with the determined concentration and wavelength to evaluate the spectral shape to determine the spectral signature for the chromophore; and

at least one chromophore and its concentration in the blood of the human or animal subject from the catalog of chromophore spectra is identified.

7. The apparatus for non-invasively determining the relative amounts of a plurality of chromophores in the blood of a human or animal subject as set forth in claim 6 wherein the light source imparts short intense pulses of visible and infrared light to the transmitting fiberoptic.

8. The apparatus for non-invasively determining the relative amounts of a plurality of chromophores in the blood of a human or animal subject as set forth in claim 6 wherein the broadband light imparted by the light source is in the range of at least about 450 nanometers to 650 nanometers.

9. The apparatus for non-invasively determining the relative amounts of a plurality of chromophores in the blood of a human or animal subject as set forth in claim 6 wherein the light delivery fiberoptic and the light collecting fiberoptic have free ends maintained in a substantially parallel relationship to define a tissue sample receiving space between the free ends of the fiberoptics.

10. The apparatus for non-invasively determining the relative amounts of a plurality of chromophores in the blood of a human or animal subject as set forth in claim 9 wherein an end surface of the light delivery fiberoptic is formed at about a 45 degree angle relative to the longitudinal axis of the fiberoptic, and an end surface of the light collecting fiberoptic is also formed at about a 45 degree angle, and both end surfaces are provided with a reflective coating thereon so that the light is directed perpendicularly through the tissue sample.

11. The apparatus for non-invasively determining the relative amounts of a plurality of chromophores in the blood of a human or animal subject as set forth in claim 6 wherein the light source comprises an incandescent lamp which is pulsed by discharging a capacitor through a filament of the lamp.

12. The apparatus for non-invasively determining the relative amounts of a plurality of chromophores in the blood of a human or animal subject as set forth in claim 6 wherein the light source comprises a short-arc xenon lamp and shutter.

13. The apparatus for non-invasively determining the relative amounts of a plurality of chromophores in the blood of a human or animal subject as set forth in claim 6 wherein the light source imparting the visible and infrared light to the light delivery fiberoptic further comprises a reference fiberoptic connected directly between the light emission timing disk and the spectrometer.

14. The apparatus for non-invasively determining the relative amounts of a plurality of chromophores in the blood of a human or animal subject as set forth in claim 13 wherein the light source imparts a plurality of sequentially different light spectra to the spectrometer within a desired time period.

15. The apparatus for non-invasively determining the relative amounts of a plurality of chromophores in the blood of a human or animal subject as set forth in claim 13 further comprising means for measuring an ambient light spectra sequentially with the light from the light delivery fiberoptic and the light from the reference fiberoptic to the spectrometer.

16. The apparatus for non-invasively determining the relative amounts of a plurality of chromophores in the blood of a human or animal subject as set forth in claim 6 wherein deconvolution of the total absorption spectra from the spectrometer is performed using a technique of developing a matrix-vector notation;

(A+γ

I)c=b 

 

(17)

where A is the N×

N matrix with elements a_m,n given by

a_m,n=∫

σ

_m(λ

)σ

_n(λ

)dλ

 

 

(14);

I is the N×

N identity matrix, c is the N-component vector whose elements are the unknown concentrations and b is the N-component vector with elements b_m given by

b_m=∫

σ

_m(λ

)F(λ

)dλ

 

 

(15);

the concentration c which solves

(A+γ

I)c=b 

 

(17)

is formally given by

c=(A+γ

I)<sup>−

1</sup>b 

 

(18)

the result of which determines the quantities or concentrations of chromophores in the blood of a human or animal subject.